Clinical Trials Browser

Phase 1 × Glioblastoma × atezolizumab × Clear all

NCT04808245 2025-09-22

INTERCEPT-H3

Phase 1 Active not recruiting

Glioblastoma, Glioma

NCT04160494 2025-05-11

D2C7-IT With Atezolizumab for Recurrent Gliomas

Phase 1 Active not recruiting

Glioblastoma, Glioma